A recent randomised trial (PARROT) of 1023 women evaluated revealed PlGF measurement with a clinical management algorithm against usual care, forming one of the largest studies of angiogenic factors in the management of suspected preterm preeclampsia. This evidence concerns the gene PGF and preeclampsia.